首页|期刊导航|河北中医|五虎汤联合布地奈德对咳嗽变异性哮喘患者肺功能及T淋巴细胞亚群的影响

五虎汤联合布地奈德对咳嗽变异性哮喘患者肺功能及T淋巴细胞亚群的影响OA

Effects of Wuhu Decoction combined with budesonide on lung function and T lymphocyte subsets in patients with cough variant asthma

中文摘要英文摘要

目的 观察五虎汤联合布地奈德对咳嗽变异性哮喘患者肺功能及T淋巴细胞亚群的影响.方法 选取2021 年 9 月至 2023 年 4 月自贡市第一人民医院中西医结合肺病科咳嗽变异性哮喘患者 140 例,随机分为对照组、治疗组,各 70 例,对照组予布地奈德吸入气雾剂治疗,治疗组在对照组基础上加五虎汤治疗.比较 2 组临床疗效、肺功能[第1 秒用力呼气容积(FEV1)、呼气峰值流量(PEF)、FEV1/用力肺活量(FEV1/FVC)]、T淋巴细胞亚群[CD4+、CD8+、CD4+/CD8+]、炎症介质[白细胞介素 6(IL-6)、血清淀粉样蛋白A(SAA)、嗜酸性粒细胞(EOS)]水平、中医证候评分及不良反应.结果 治疗后,2 组 FEV1、PEF、FEV1/FVC、CD4+、CD4+/CD8+水平均升高(P<0.05),且治疗组高于对照组(P<0.05).治疗后,2 组CD8+、IL-6、SAA、EOS水平及中医证候评分均降低(P<0.05),且治疗组均低于对照组(P<0.05).治疗组总有效率为 94.29%(66/70),高于对照组的 75.71%(53/70)(P<0.05).治疗组总不良反应率为8.57%(6/70),低于对照组的 21.43%(15/70)(P<0.05).结论 五虎汤联合布地奈德可有效改善咳嗽变异性哮喘患者肺功能和T淋巴细胞亚群分布,抑制机体炎症,疗效显著,安全性良好.

Objective To analyze the effects of Wuhu Decoction combined with budesonide on lung function and T lymphocyte subsets in patients with cough variant asthma(CVA).Methods A total of 140 CVA patients treated in the Department of Pulmonary Diseases of Zigong First People's Hospital from September 2021 to April 2023 were randomly assigned into treatment group(n=70)and control group(n=70).All patients were managed by budesonide inhalation aerosol,and those in treatment group were additionally treated with Wuhu Decoction.The curative effect,lung function(forced expiratory volume in one second[FEV1],peak expiratory flow[PEF],FEV1/forced vital capacity[FEV1/FVC]),T lymphocyte subsets[CD4+,CD8+,CD4+/CD8+],inflammatory mediators[interleukin-6[IL-6],serum amyloid A[SAA],eosinophil[EOS]),traditional Chinese medicine(TCM)syndrome score,adverse reactions were included as comparators between the two groups.Results After treatment,the levels of FEV1,PEF,FEV1/FVC,CD4+,CD4+/CD8+in the both groups were significantly increased(P<0.05),which were significantly increased in the treatment group than in the control group(P<0.05).The levels of CD8+,IL-6,SAA,EOS and TCM syndrome scores in the both groups were significantly decreased(P<0.05),the decreases in the treatment group were more prevalent compared with the control group(P<0.05).The overall effective rate in the treatment group was significantly higher than that in the control group(94.29%[66/70]vs 75.71%[53/70],P<0.05).The total incidence of adverse reactions in the treatment group was significantly lower than that in the control group(8.57%[6/70]vs 21.43%[15/70],P<0.05).Conclusion Wuhu Decoction combined with budesonide has significant therapeutic effects in CVA patients,which can effectively improve lung function and T lymphocyte subset distribution,inhibit inflammation,and with good safety.

曾红萍;陈新;朱琦;陈喻;丁倩;何艳秋

四川省自贡市第一人民医院中西医结合肺病科,四川 自贡 643000四川省自贡市第一人民医院中西医结合肺病科,四川 自贡 643000四川省自贡市第一人民医院中西医结合肺病科,四川 自贡 643000四川省自贡市第一人民医院检验科,四川 自贡 643000四川省自贡市第一人民医院中西医结合肺病科,四川 自贡 643000四川省自贡市第一人民医院中西医结合肺病科,四川 自贡 643000

医药卫生

咳嗽变异性哮喘五虎汤布地奈德肺功能T淋巴细胞亚群

Cough variant asthmaWuhu DecoctionBudesonideLung functionT lymphocyte subsets

《河北中医》 2026 (3)

381-384,391,5

四川省中医药管理局科学技术研究专项课题(编号:2021MS462)自贡市财政局自贡市科学技术局2021年第一批市级科技计划项目(编号:2021YXY01)自贡市卫生健康委员会自贡市卫生健康科研课题(编号:19yb009)

10.3969/j.issn.1002-2619.2026.03.006

评论